CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 111 enrolled
Drug / intervention
DFD-07 Cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02654717
NCT02654717Phase 2Completed
CompareCT.gov

Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp

Promius Pharma, LLC·interventional·Posted Jan 13, 2016·Updated Mar 17, 2020

In Brief

A Phase 2 clinical trial evaluating DFD-07 Cream and Placebo Cream for Actinic Keratosis. Completed, enrolled 111 participants across 3 sites.

Detailed Summary

The purpose of this study is to see how well DFD-07 works in treating actinic keratosis on the face and scalp during 8 weeks of treatment. The study will also look at any unwanted effects of the study drug.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsActinic Keratosis
CountriesGermany
Collaborators--

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 13, 2016
Enrollment StartNov 1, 2015
Primary CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.5 years ago

Interventions

DFD-07 Creamdrug

Placebo Creamdrug